Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elif Everest

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Neuropsychiatry|April 29, 2026
Investigating the Pleiotropic Role of KIF21B in Schizophrenia and Multiple Sclerosis: A Bioinformatics AnalysisEla Doruk Korkmaz, Elif Everest
Clinical Neuropsychiatry|January 1, 2026
Genetic Risk, Self-Harm, and Violence in Schizophrenia: A Narrative Review of Implications for Early Identification and InterventionEla Doruk Korkmaz, Elif Everest
Cerebellum (London, England)|September 16, 2023
A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coincidental or Associated?Elif Everest, Bade Gulec, Ugur Uygunoglu
Turk Pediatri Arsivi|October 25, 2017
Role of genetics in pediatric rheumatologyEda Tahir Turanlı, Elif Everest, Ayşe Balamir, et al.
Annals of Clinical and Translational Neurology|April 10, 2026
Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised ClusteringBade Gulec, Elif Everest, Melih Tutuncu, et al.
Genetics and Molecular Biology|September 2, 2017
Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture modelsGokce Celikyapi Erdem, Sule Erdemir, Irem Abaci, et al.
European Journal of Neurology|June 10, 2023
Comparison of multiple sclerosis patients with or without rebound activity after fingolimod cessation: Five-year clinical outcomesBade Gulec, Elif Everest, Ogeday Derin Gorkey, et al.
Peerj|November 15, 2024
Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic dataElif Everest, Ege Ülgen, Ugur Uygunoglu, et al.
Molecular Genetics and Genomics : MGG|June 15, 2022
MYO1H is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegiaEce Selçuk, Koray Kırımtay, Benan Temizci, et al.
Rheumatology (Oxford, England)|January 24, 2023
Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotypeMerve Özkılınç Önen, Umut I Onat, Serdal Uğurlu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Neuropsychiatry|April 29, 2026
Investigating the Pleiotropic Role of KIF21B in Schizophrenia and Multiple Sclerosis: A Bioinformatics AnalysisEla Doruk Korkmaz, Elif Everest
Clinical Neuropsychiatry|January 1, 2026
Genetic Risk, Self-Harm, and Violence in Schizophrenia: A Narrative Review of Implications for Early Identification and InterventionEla Doruk Korkmaz, Elif Everest
Cerebellum (London, England)|September 16, 2023
A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coincidental or Associated?Elif Everest, Bade Gulec, Ugur Uygunoglu
Turk Pediatri Arsivi|October 25, 2017
Role of genetics in pediatric rheumatologyEda Tahir Turanlı, Elif Everest, Ayşe Balamir, et al.
Annals of Clinical and Translational Neurology|April 10, 2026
Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised ClusteringBade Gulec, Elif Everest, Melih Tutuncu, et al.
Genetics and Molecular Biology|September 2, 2017
Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture modelsGokce Celikyapi Erdem, Sule Erdemir, Irem Abaci, et al.
European Journal of Neurology|June 10, 2023
Comparison of multiple sclerosis patients with or without rebound activity after fingolimod cessation: Five-year clinical outcomesBade Gulec, Elif Everest, Ogeday Derin Gorkey, et al.
Peerj|November 15, 2024
Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic dataElif Everest, Ege Ülgen, Ugur Uygunoglu, et al.
Molecular Genetics and Genomics : MGG|June 15, 2022
MYO1H is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegiaEce Selçuk, Koray Kırımtay, Benan Temizci, et al.
Rheumatology (Oxford, England)|January 24, 2023
Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotypeMerve Özkılınç Önen, Umut I Onat, Serdal Uğurlu, et al.
Pageof 3